Search PubMedSearch

Biomedical subjects

R Keys

Publications and source records attributed to R Keys.

3 recordsLinked to original sources

Two novel Streptomyces protein protease inhibitors. Purification, activity, cloning, and expression.

In contrast to the Gram-negative bacteria, Gram-positive bacteria such as Streptomyces lack a mucopolysaccharide cell wall which allows them to produce and secrete a variety of proteins directly into their environment. In an effort to understand and eventually exploit the synthesis and secretion of proteins by Streptomyces, we identified and characterized two naturally occurring abundantly produced proteins in culture supernatants of Streptomyces lividans and Streptomyces longisporus. We purified these 10-kDa proteins and obtained partial amino acid sequence information which was then used to design oligonucleotide probes in order to clone their genes. Analysis of the sequence data indicated that these proteins were related to each other and to several other previously characterized Streptomyces protein protease inhibitors. We demonstrate that both proteins are protein protease inhibitors with specificity for trypsin-like enzymes. The presumptive signal peptidase cleavage sites and subsequent aminopeptidase products of each protein are characterized. Finally, we show that the cloned genes contain all of the information necessary to direct synthesis and secretion of the proteins by Streptomyces spp. or Escherichia coli.

Amino Acid Sequence

Allele-specific activation of genetically engineered receptors.

The binding of agonists and antagonists to the beta-adrenergic receptor (beta AR) is postulated to involve an ionic interaction between the amine group of the ligand and the carboxylate side chain of Asp113 in the third hydrophobic domain of the receptor. To explore the importance of this interaction in the binding of ligands to the beta AR, a Ser residue was substituted for Asp113, and the ability of this mutant receptor to respond to compounds which could potentially interact with the hydroxyl side chain of the Ser residue was assessed. The mutant receptor was fully activated by catechol-containing esters and ketones, compounds which did not activate the wild-type beta AR. The demonstration that the molecular substitution of a single amino acid residue can alter the ligand binding specificity of the beta AR provides evidence that the chemical nature of this residue is a critical determinant in the recognition site of the receptor. Further, the ability to modify the specificity of a receptor by the replacement of amino acids at the binding site demonstrates the potential for the rational design of drugs which function specifically at genetically engineered receptors.

Adenylyl Cyclase Inhibitors

Gapping fields on sloping surfaces.

The accurate positioning of treatment fields has always been difficult, and becomes even more important when two fields are adjacent and a gap must be calculated. The standard formula (based on similar triangles) assumes a flat surface. In Hodgkin's patients the gapping between the mantle and para-aortic fields involve sloping surfaces and the patient thickness can vary as much as 5 or 6 cm between central axis and the lower edge of the mantle field. Due to the divergence of a large mantle field, using the standard formula and gapping on the skin surface can lead to an overlap of 7 to 9 mm and a region which can receive 140% of the midplane dose. A modification of the existing formula which takes into account sloping surfaces has been formulated for both source-skin-distance and isocentric treatments. In addition, problems in positioning related to mantle fields when treating the patient prone and supine have been investigated.

Hodgkin Disease